Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1979 Apr;36(1):1–7.

Research in leprosy. A report of a committee set up by the medical research council to study future prospects.

PMCID: PMC1537685  PMID: 380853

Abstract

Recommendations for future research in leprosy include (i) cultivation of M. leprae in vitro; (ii) genetic control of susceptibility, including twin studies and HLA typing; (iii) precise antigenic analysis of M. leprae; (iv) mechanisms involved in the macrophage response to mycobacterial infections; (v) more use of experimental models such as normal mice infected with M. lepraemurium; (vi) reassessment of the protection afforded by BCG; (vii) assessment of protection afforded by killed (armadillo) M. leprae vaccine; (viii) pathogenesis of erythema nodosum leprosum including a study of the effect of thalidomide; and (ix) development of in vitro systems for drug sensitivity testing.

Full text

PDF
7

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjorvatn B., Barnetson R. S., Kronvall G., Zubler R. H., Lambert P. H. Immune complexes and complement hypercatabolism in patients with leprosy. Clin Exp Immunol. 1976 Dec;26(3):388–396. [PMC free article] [PubMed] [Google Scholar]
  2. Bjune G., Barnetson R. S., Ridley D. S., Kronvall G. Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions. Clin Exp Immunol. 1976 Jul;25(1):85–94. [PMC free article] [PubMed] [Google Scholar]
  3. Davey T. F., Rees R. J. The nasal dicharge in leprosy: clinical and bacteriological aspects. Lepr Rev. 1974 Jun;45(2):121–134. doi: 10.5935/0305-7518.19740014. [DOI] [PubMed] [Google Scholar]
  4. Ellard G. A., Gammon P. T., Rees R. J., Waters M. F. Studies on the determination of the minimal inhibitory concentration of 4,4'-diamino-diphenyl-sulphone (Dapsone, DDS) against Mycobacterium leprae. Lepr Rev. 1971 Jun;42(2):101–117. doi: 10.5935/0305-7518.19710013. [DOI] [PubMed] [Google Scholar]
  5. Harboe M., Closs O., Bjorvatn B., Bjune G. Antibodies against BCG antigen 60 in mycobacterial infection. Br Med J. 1977 Aug 13;2(6084):430–433. doi: 10.1136/bmj.2.6084.430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Khanolkar S. R., Ambrose E. J., Chulawala R. G., Bapat C. V. Autoradiographic and metabolic studies of Mycobacterium leprae. Lepr Rev. 1978 Sep;49(3):187–198. [PubMed] [Google Scholar]
  7. Myrvang B., Godal T., Ridley D. S., Fröland S. S., Song Y. K. Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy. Clin Exp Immunol. 1973 Aug;14(4):541–553. [PMC free article] [PubMed] [Google Scholar]
  8. Pearson J. M., Haile G. S., Rees R. J. Primary dapsone-resistant leprosy. Lepr Rev. 1977 Jun;48(2):129–132. doi: 10.5935/0305-7518.19770016. [DOI] [PubMed] [Google Scholar]
  9. Pearson J. M., Rees R. J., Waters M. F. Sulphone resistance in leprosy. A review of one hundred proven clinical cases. Lancet. 1975 Jul 12;2(7924):69–72. doi: 10.1016/s0140-6736(75)90508-5. [DOI] [PubMed] [Google Scholar]
  10. Rees R. J., McDougall A. C. Airborne infection with Mycobacterium leprae in mice. J Med Microbiol. 1977 Feb;10(1):63–68. doi: 10.1099/00222615-10-1-63. [DOI] [PubMed] [Google Scholar]
  11. Rees R. J., Waters M. F., Pearson J. M., Helmy H. S., Laing A. B. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies. Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):159–169. [PubMed] [Google Scholar]
  12. Ridley D. S., Jopling W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255–273. [PubMed] [Google Scholar]
  13. Shepard C. C., Walker L. L., van Landingham R. Heat stability of Mycobacterium leprae immunogenicity. Infect Immun. 1978 Oct;22(1):87–93. doi: 10.1128/iai.22.1.87-93.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Stoner G. L., Touw J., Belehu A., Naafs B. In-vitro lymphoproliferative response to Mycobacterium leprae of HLA-D-identical siblings of lepromatous leprosy patients. Lancet. 1978 Sep 9;2(8089):543–547. doi: 10.1016/s0140-6736(78)92881-7. [DOI] [PubMed] [Google Scholar]
  15. Waters M. F., Rees R. J., McDougall A. C., Weddell A. G. Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli. Lepr Rev. 1974 Dec;45(4):288–298. doi: 10.5935/0305-7518.19740034. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES